- United States
- /
- Semiconductors
- /
- NasdaqGM:MRAM
Everspin Technologies (MRAM) Q4 Profitability Return Challenges Bearish Earnings Narratives
Everspin Technologies (MRAM) closed FY 2025 with Q4 revenue of US$14.8 million and basic EPS of US$0.05, alongside net income of US$1.2 million. On a trailing 12 month basis, revenue was US$55.2 million and the business remained loss making with a basic EPS loss of US$0.03 and a net income loss of US$0.6 million. The company has seen quarterly revenue move from US$13.2 million in Q2 FY 2025 to US$14.1 million in Q3 and US$14.8 million in Q4, with EPS shifting from a loss of US$0.05 in Q1 FY 2025 to a modest profit of US$0.05 in Q4. This sets up a results season where improving quarterly profitability sits alongside still thin margins and a mixed earnings profile.
See our full analysis for Everspin Technologies.With the headline numbers on the table, the next step is to see how these results line up with the prevailing stories about growth, profitability and risk that investors have been debating around Everspin.
See what the community is saying about Everspin Technologies
55.2m in sales, but trailing loss still US$0.6m
- On a trailing 12 month view to Q4 FY 2025, Everspin booked US$55.2 million of revenue and a net loss of US$0.6 million, even though Q4 itself was profitable with US$1.2 million of net income.
- Analysts' bullish narrative leans on MRAM adoption in areas like data centers, automotive and aerospace. However, the 7.6% trailing 12 month revenue growth rate and ongoing losses mean investors are still waiting for that broader adoption to consistently show up in both higher sales and sustained profitability.
Investors who want to see how this tension between growing MRAM use cases and still-loss making trailing numbers plays out over time can check how the community is weighing those trade offs in See what the community is saying about Everspin Technologies.
Price to sales at 3.8x, DCF fair value at US$2.44
- Everspin trades on a P/S of 3.8x, which is below both the peer average of 7.1x and the US Semiconductor industry at 6x, while the current share price of US$9.12 sits well above a DCF fair value estimate of US$2.44.
- What challenges the bullish camp is that even with multi year loss reduction at about 14.6% per year and a P/S below peers, the stock price being above the DCF fair value suggests the market is already baking in stronger outcomes than that cash flow model implies. Investors need to be clear which yardstick they trust more.
- If you lean on sales multiples, the 3.8x P/S against higher peer averages can look appealing on a relative basis.
- If you lean on cash flow estimates, the gap between US$9.12 and the US$2.44 DCF fair value points to a very different risk reward picture.
Forecast earnings swings and insider selling risks
- The analysis flags a major risk that earnings are forecast to decline by an average of 44.8% per year over the next three years, alongside minor risks from recent share price volatility and significant insider selling in the last three months.
- Bears argue that reliance on specialized contracts and niche end markets, combined with these projected earnings declines, makes the business vulnerable. The combination of forecast earnings pressure plus insider selling gives that cautious view some concrete numbers to point to even as the company has been reducing losses over a five year period.
- The projected 44.8% annual earnings decline sits uncomfortably next to the expectation in other parts of the analysis that the company could become profitable within three years.
- Volatile trading and insider selling add timing risk, since any disappointment against those mixed forecasts can quickly feed into short term price moves.
Next Steps
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Everspin Technologies on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
Uncertain about how all these moving parts fit together for you personally? Take a moment to review the data, weigh the upside against the red flags, and focus on the 3 important warning signs before you decide what this story means for your portfolio.
Explore Alternatives
Everspin combines a trailing 12 month loss of US$0.6m, earnings forecast to decline 44.8% per year, and insider selling, which raises clear risk questions.
If that mix of thin profitability, projected earnings pressure and insider activity makes you cautious, it could be worth shifting your attention toward 73 resilient stocks with low risk scores, which aim to prioritise steadier profiles and clearer downside protection.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Everspin Technologies might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NasdaqGM:MRAM
Everspin Technologies
Manufactures and sells magnetoresistive random access memory (MRAM) technologies in the United States, Japan, Hong Kong, Germany, Singapore, Canada, and internationally.
Flawless balance sheet with reasonable growth potential.
Similar Companies
Market Insights
Weekly Picks

This small biotech is developing technology that could potentially change how tissue is rebuilt

The Picks-and-Shovels Leader of the Grid Supercycle
KRMN — Karman Space & Defense: Down 58% from Peak, Is the Market Mispricing a Hypergrowth Defense Compounder?

Invinity Energy Systems: All About That BESS
Recently Updated Narratives

Oracle - A Fundamental and Historical Valuation

Australia’s Next Silver Giant, PEA Delivers A$377M NPV & 37% IRR on Just 22% of Resource

American Resources, $263M Market Cap + 19% ReElement Stake, From Coal to Critical Minerals
Popular Narratives

Investment Analysis (May 2026)

Adobe: A Probabilistic Case for Undervaluation
